Author: de Figueiredo, A

This article reflects on recent research examining the levels and trends of vaccine confidence over time and across the globe, the drivers influencing confidence, and the role of the COVID-19 pandemic in shaping confidence today.

An examination of trends in vaccine confidence across eight sub-Saharan countries between 2020 and 2022.

The latest WHO/UNICEF estimates of national childhood immunisation coverage have revealed the largest declines in routine immunisation uptake globally in three decades. Through a large-scale retrospective modelling study, we investigate the extent to which vaccine confidence has changed globally using pre- and post-pandemic.

Read the 2022 instalment of the VCPs bi-annual research report “The State of Vaccine Confidence in the EU,” which monitors public attitudes to vaccines across the continent.

COVID-19 vaccination policies have prompted much debate, yet there has been limited evaluation of their potential unintended consequences. Here, we outline a comprehensive set of hypotheses for why these policies may ultimately be counterproductive and harmful.

In this study, we explore how intent to receive a COVID-19 vaccine evolved in Nigeria (both nationally and sub-nationally) between March 2021 (when the first vaccines were administered to healthcare workers) and October 2021.

We conducted a large-scale national survey in the UK of 17,611 adults between 9 and 27 April 2021. Bayesian multilevel regression and poststratification is used to provide unbiased national-level estimates of the impact of the introduction of vaccine passports on inclination to accept COVID-19 vaccines.

Between October 31, 2020 and December 15, 2020, 26,759 individuals were surveyed across 32 countries via nationally representative survey designs.

Here we predict uptake of the vaccine at unprecedented spatial resolution across the UK using a large-scale survey of over…

To inform successful vaccination campaigns, we conducted a randomized controlled trial in the UK and…

In this large-scale retrospective data-driven analysis, we examined global trends in vaccine…

In November 2017, it was announced that the new dengue vaccine (“Dengvaxia”) had risks…